AptarGroup realigns segments into Pharma, Beauty, Closures; recasts 2022 & 2021 data

APTARGROUP, INC.

Effective Jan 1, 2023: combined all closures into Aptar Closures; renamed Beauty+Home to Aptar Beauty.
FY 2022 net sales $3.32B (up 2.9% YoY); adjusted EBITDA $616.7M vs $607.5M in 2021.
Aptar Closures FY 2022 adjusted EBITDA margin 11.7%, down from 14.3% in 2021.
Aptar Beauty FY 2022 adjusted EBITDA margin 12.4%, up from 10.6% in 2021.
Recast quarterly and annual segment revenue and adjusted EBITDA furnished for 2022 and 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.